Recent News and Articles on the Keywords: cancer + new + weakens  Related to the article below (Last Update: 12/1/2008)

 News results: Standard Version | Text Version | Image Version Results 1 - 10 of about 354 for cancer new weakens. (0.14 seconds) 
Recent
Archives
  • All dates
  • 1997-2008
  • 1993-95
  • 1990-92
  • 1980s

 Sorted by relevance   Sort by date   Sort by date with duplicates included 
In space, a cluster of health dangers
Philadelphia Inquirer, PA - Nov 30, 2008
A Mars mission would take at least six months each way, during which the crew would face unknown dangers - cancer, depression, dementia, ...
Revealing Some Secret and Unknown Facts about Cancer
Canada Free Press, Canada -
Certain forms of radiation therapy are known to both kill healthy cells while expediting the growth of new cancer cells in an individual. ...

Houston Chronicle
You Docs: America's favorite physicians give advice
Houston Chronicle, United States -
Low levels can literally rewrite your DNA, raising cancer risk by muting your tumor-suppressing genes and weakening chromosomes. The facts: High-dose folic ...
Lower-cost drugs predicted under Obama administration
Chicago Tribune, United States - Nov 30, 2008
Such a move would open the door to innovations for cancer and anemia and other treatments that are derived from human or animal cells and can cost tens of ...
AP Health NewsBrief at 3:21 am EST
TMCnet - Nov 27, 2008
Encouraging dip in rate of new cancers, deathsWASHINGTON (AP) _ The rate of new cancer cases finally may be inching down _ cautiously optimistic news but a ...

News Virginian
Undefined by a disease
News Virginian, VA -
AIDS, acquired immunodeficiency syndrome, is the set of opportunistic diseases that attack the human body after the HIV virus weakens the immune system. ...
Theralase Technologies Announces 2008 Third Quarter Results 3Q ...
PR-USA.net (press release), Bulgaria - 34 minutes ago
The TLC-3000 will be used to activate Theralase's patented Photo Dynamic Compounds (PDCs) in the presence of additional cancer cell lines. ...CVE:TLT - TSE:X
Time to quit smoking
The Snapper, PA - Nov 19, 2008
Smoking also quickens the disease of osteoporosis, which is a disease that weakens all the bones in your body. This allows you to break bones easier and to ...
Baseball says welcome back to Baylor
SportingNews.com - Nov 27, 2008
Baylor didn't understand any of this until it was learned he'd been diagnosed with multiple myeloma -- a cancer that attacks the blood plasma and weakens ...

Healthy Wealthy n Wise
Alkalinity ? The Secret to Abundant Energy and Life-Long Health By ...
Healthy Wealthy n Wise, WV -
Several years later, 2-time Nobel Prize winner Dr. Linus Pauling was the first to show that cancer cells are unable grow in an oxygen-rich, ...
Source: Google News


 

Recent News and Articles on the Keywords: new + drug + cancer  Related to the article below (Last Update: 8/5/2008)

Lorus Toxicology Program Supports Novel Route of Administration of ...
FOXBusiness -
... supports Lorus' plan to submit an Investigational New Drug (IND) application for the use of LOR-2040 in the treatment of bladder cancer during Q4, 2008. ...LRP - OTC:CMTX
Medarex Announces Allowance of Investigational New Drug ...
CNNMoney.com (press release) -
We look forward to exploring the potential of MDX-1105 as a possible new treatment option for patients with cancer and infectious disease. ...MEDX
GTx loses more than $13M in 2Q
Bizjournals.com, NC -
Those revenues came from $274000 in sales from breast cancer drug Fareston and $2.8 million in collaboration funds from drug makers Ipsen Limited and Merck ...
GTx reports wider net loss in Q2 on higher expenses - Update RTT News
GTx, Inc. Reports Second Quarter 2008 Financial Results StreetInsider.com (subscription)
all 14 news articles »  GTXI
Promising early results for new prostate cancer drug
OnMedica, UK -
One of the biggest stories recently has been about abiraterone ? an experimental new drug for prostate cancer that could potentially treat ?80 per cent of ...
Craig W. Philips Takes Helm at CTI
FOXBusiness -
"With the opportunity to bring two new cancer drugs to market and expand the label of another in the near term, CTI could transform itself into a successful ...CTIC - OTC:CMTX
Allos Therapeutics Reports 2008 Second Quarter Results
MarketWatch -
We expect to report top line results of the trial by the end of 2008 and, following our review of the trial results, to submit a New Drug Application for ...ALTH
Cancer Drugs or Vacation Spas: Take Your Pick
Metropolitan News-Enterprise, CA -
It appears a pharmaceutical company has come up with a new drug that treats lung cancer. The average cost for use of this lifesaving drug is $56000. ...
Saladax Biomedical Enters Agreement With Karolinska University ...
MarketWatch -
Final assay development is underway for the highest volume anti-cancer drugs. For more information about Saladax, visit www.saladax.com. ...

Seattle Times
Icahn Calls Bristol Bid Too Low, Weighs ImClone Split (Update2)
Bloomberg - Aug 4, 2008
Bristol-Myers, of New York, was the world's biggest seller of cancer medicine before its drug Taxol faced competition from cheaper copies in 2001. ...
Rates on short-term Treasury bills rise San Diego Union Tribune
ImClone calls Bristol offer too low Reuters
In Bristol-ImClone Showdown, Watch Wilmington Forbes
Las Vegas Review - Journal
all 762 news articles »  IMCL - BMY - PGIC
John Gotti Jr arrested in New York
guardian.co.uk, UK -
The charges that will be pressed on him are understood to relate to a drug ring operated in New York, New Jersey and Florida and the killings that date back ...
AssociatedPress
FBI: John "Junior" Gotti Arrested In Connection With Mob Hits WNBC
John "Junior" Gotti, Jr. Arrested on Three Murder Conspiracy Charges Associated Content
all 1,086 news articles »
Source: Google News

New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening -
P Skehan, R Storeng, D Scudiero, A Monks, J … - jnci, 1990 - jnci.oxfordjournals.org
... for the Potential Treatment of Drug-Resistant Ovarian ... Home page, JNCI J Natl Cancer
Inst Home page Si ... Antitumor activity of ZSTK474, a new phosphatidylinositol 3 ...

Docetaxel: an Active New Drug for Treatment of Advanced Epithelial Ovarian Cancer -
MJ Piccart, M Gore, WTB Huinink, A Van Oosterom, J … - jnci, 1995 - jnci.oxfordjournals.org
... 87, No. 9, 676-681, May 3, 1995 ? 1995 Oxford University Press Docetaxel: an Active
New Drug for Treatment of Advanced Epithelial Ovarian Cancer. ...

[PDF] NEW FUNCTIONS FOR THE MATRIX METALLOPROTEINASES IN CANCER PROGRESSION -
M Egeblad, Z Werb - Nature Reviews Cancer, 2002 - microarray.princeton.edu
... extracellular matrix, and that they function before invasion in the development
of cancer. ... CLINICAL TRIALS Phase I: the first testing of a new drug in humans.A ...
-

Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein -
WS Dalton - Cancer Research, 1986 - AACR
... Is a Key Determinant in de Novo Multidrug Resistance (MDR): New Targets for ...
P-Glycoprotein and Mrp1 to Basal Drug Resistance Cancer Res., October 1 ...

Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy -
N Immunology, D Discovery - Nature Medicine, 2001 - palgrave-journals.com
... angiogenic scheduling of chemotherapy improves efficacy against experimental
drug?resistant cancer ... Cancer Res ... E. et al.) 517?530 (McGraw-Hill, New York, 2001 ...

Application of a human tumor colony-forming assay to new drug screening -
RH Shoemaker - Cancer Research, 1985 - AACR
... of feasibility, validity, and potential for discovering new antitumor drugs. ... which
were negative in the current National Cancer Institute prescreen ...

Histone deacetylase inhibitors as new cancer drugs. -
PA Marks, VM Richon, R Breslow, RA Rifkind - Current Opinion in Oncology, 2001 - co-oncology.com
... Histone deacetylase inhibitors as new cancer drugs. Marks ... necropsy. Histone
deacetylase inhibitors in clinical trials as new cancer drugs TOP. ...

An investigational new drug treatment program for patients with gemcitabine: results for over 3000 … -
AM Storniolo, NH Enas, CA Brown, M Voi, ML … - Cancer, 1999 - ncbi.nlm.nih.gov
Cancer. 1999 Mar 15;85(6):1261-8. Click here to read An investigational new drug
treatment program for patients with gemcitabine: results for over 3000 ...

Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. -
A Yagoda, D Petrylak - Cancer, 1993 - ncbi.nlm.nih.gov
1993 Feb 1;71(3 Suppl):1098-109. Comment in: Invest New Drugs. 2002 May;20(2):143-
4. Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. ...

… the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer -
GJ Zaman - Cancer Research, 1993 - AACR
... ARTICLES. Analysis of the expression of MRP, the gene for a new putative transmembrane
drug transporter, in human multidrug resistant lung cancer cell lines. ...

Source: Google Scholar
 

   
   

New Drug Weakens Cancer Cells

Researchers say they're making headway towards a drug that weakens cancer cells without exposing the body to the destructive effects of chemotherapy and radiation.

Tumors in cancer-ridden mice shrank by 90 percent after treatment with the drug, researchers report in a study to be released Tuesday. The compound, called OGT2378, appears to block the ability of cancer cells to grow by manipulating the host's immune system.

However, the research is still in the preliminary stages and the treatment is certainly not a cure, cautioned study co-author Dr. Stephan Ladisch, director of the Center for Cancer and Immunology Research at the Children's Research Institute in Washington, D.C.

The goal of the researchers is to dampen the production of gangliosides, molecules found on the edges of cells. In tumors, these molecules create a kind of "cloud" around cancerous cells that hijacks healthy cells, Ladisch explained.

"Putting all of this together made us think -- what would happen if we were able to interrupt this process? Suppose we could stop the release of these molecules? Would that stop the ability of [tumors] to form?" Ladisch said. "The answer to that is 'yes.'"

Ladisch and colleagues were to report their findings at the American Chemical Society annual meeting, in Washington, D.C.

Tumors were much smaller in mice treated with OGT2378, a chemical compound already used in metabolic disease drugs. The compound, a carbohydrate, seems to block enzymes that cancer cells need to create gangliosides.

The findings are good news, but more research must be done, Ladisch said, and testing in humans will be key. "You can't be sure that there might not be a toxicity that wasn't noticed," he said.

Still, the approach is "promising," said James Paulson, a cancer researcher and director of the Consortium for Functional Glycomics at the Scripps Research Institute in San Diego.

"It will be interesting to see if this drug, in combination with existing therapies that kill cancer cells, will lead to more effective regimens for increasing rates of cancer remission and cure."

More information

Learn more about cancer treatment from the American Cancer Society.

Health Tip: Avoid Alcohol While Breastfeeding

August 30, 2005 08:41:01 PM PST

Breastfeeding mothers should avoid drinking alcohol, advises Baylor College of Medicine in Houston. Alcohol is readily passed into breast milk, and heavy drinking or a daily drink can harm your baby.

A baby's body metabolizes alcohol very slowly, so even a small amount can affect nursing and sleep patterns. Regular alcohol exposure can also affect a baby's behavior and coordination.

If you're craving a drink, you can limit yourself to an occasional single three-ounce glass of wine -- then wait two hours or more before nursing your baby. This way, your body will be able to clear both your blood and milk of alcohol.

 

Continue with:

H2

H3

H4

H5

H6

H7

H8

H9

H9A

 

 © 2002-2006

Keywords:

Contact Iconocast

Home Page